Periodic Reporting for period 4 - REGENETHER (Modeling and treating retinal degenerative disease)

Adeno-associated virus (AAV) vector-based gene therapy has showed early promise in clinical trials. Different AAV capsid pseudotypes can be used to package the therapeutic transgenic cassette, each with its own transduction profile. Currently, the efficiency of AAV capsid...